Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-77

Gassy in all fairness with ref to brokers supporting,
who is actually supporting who, what with commissioned write ups at what cost to us, i Have absolutely no idea they are obviously having little to no effect on our SP and a recent cost of $1.7 mil in fees for the so called broker support in the last CR

It does actually beg the question
Who is actually supporting who
Appears to me, more like we are supporting them

I have no idea what all this spark + association is about, i am beginning to wonder if we have a singapore mob waiting in the wings for a cheap issue, at which point we will be advised it was the best we could get in the present market climate

Why did we not present at the San fran bio convention
Why did we not present at the recent San diego bio convention
Both massive exposure to VCs seeking to invest and companies looking to partner

With serious funds available funds that could take us to futility and beyond, like the funds pepgen recently acquired in their $150mil Au equivalent to advance a ph1 trial on DMD

Yet time after time we persist with Spark +

It just does not add up and believe you me, i am worried from a financial front just exactly what they are going to dish up to us next

Why you may say

well ask yourself are they making the right kind of noises in the league they are looking to move into

Personally i think not, if they can publicise a singapore roadshow they can publicise a US roadshow, its not like they have not had the opportunity with the massive exposure to the two, now past opportunities in the US, so i can only take from that that they are seriously not looking in the US direction for reasons unknown
I am bewildered to say the very least

Enjoy your wkends